Suchergebnisse - "Myeloma"

PubPharm (16)

1

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2017

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

2

Pharmacokinetics of Daratumumab Following Intravenous Infusion in Relapsed or Refractory Multiple Myeloma After Prior Proteasome Inhibitor and Immunomodulatory Drug Treatment

enthalten in: Clinical pharmacokinetics | 2016

von Clemens, P. | Yan, X. | Lokhorst, H. | +9

3

Daratumumab in multiple myeloma: a guide to its use as monotherapy in the EU

enthalten in: Drugs & therapy perspectives | 2016

von McKeage, K. | Lyseng-Williamson, K.

4

Daratumumab in multiple myeloma: a guide to its use as monotherapy in the EU

enthalten in: Drugs & therapy perspectives | 2016

von McKeage, K. | Lyseng-Williamson, K.

5

Daratumumab: a first-in-class CD38 monoclonal antibody for the treatment of multiple myeloma

enthalten in: Journal of hematology & oncology | 2016

von Sanchez, L. | Wang, Y. | Siegel, D. | +1

6

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

enthalten in: Drugs | 2016

von Moreau, P. | van de Donk, N. | Miguel, J. | +17

7

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

enthalten in: Drugs | 2016

von Moreau, P. | van de Donk, N. | Miguel, J. | +17

8

Practical Considerations for the Use of Daratumumab, a Novel CD38 Monoclonal Antibody, in Myeloma

enthalten in: Drugs | 2016

von Moreau, P. | van de Donk, N. | Miguel, J. | +17

9

Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma

enthalten in: Targeted oncology | 2016

von Greig, S.

10

Panobinostat: A Review in Relapsed or Refractory Multiple Myeloma

enthalten in: Targeted oncology | 2016

von Greig, S.